Leen Kawas | Entrepreneur, Inventor, Innovator and Leader | Managing General Partner at Propel Bio Partners. In today’s technology-driven business world, innovation is the engine that drives new products, services and applications. In the biotechnology industry role, I see diverse types of innovation on a daily basis. Each breakthrough springs from an integration of factors that spur bold thinking and bring exciting discoveries.

While some learners appreciate the idea of preparation and planning, others have higher risk tolerance and are more than happy to dive right into any task and “learn by doing”. Both methodologies can be positively impactful in a professional setting, and can together be wildly successful. However, with such different…

Biotechnology companies’ continued growth is dependent on multiple factors. Every biotech business needs a promising concept, the founder’s expertise and determination, and sufficient financial resources. Talented team members, typically with highly specialized skill sets, are also key to the organization’s forward progress. Leen Kawas, Ph.D. is Propel Bio Partners’ Managing…

In today’s rapidly evolving digital world, companies across the globe are integrating artificial intelligence (or AI) into their business operations. Businesses of varied types and sizes now regularly use AI in multiple ways. The investment and financial industry is no different and is a good example of this technology adoption…

Learning a valuable skill, or successfully navigating a workplace challenge, often takes careful planning and plenty of practice. Alexander Graham Bell said it best: “Before anything else, preparation is the key to success.” However, another large cohort takes the opposite approach. They “learn by doing,” plowing through each task in…

Leen Kawas | Entrepreneur, Inventor, Innovator and Leader | Managing General Partner at Propel Bio Partners. While companies of all sizes across various industries adapt their processes to make room for innovative artificial intelligence (AI), the financial and investment industry is catching up and leveraging AI tools to enhance their operations and improve their performance. I’m seeing that the financial industry and investment firms can and are implementing various AI tools to help boost their productivity, error margins and overall efficiency.

Dr. Leen Kawas, Managing General Partner at Propel Bio Partners, highlights the need to remove the glass ceiling in the biotech industry. As the United States biotechnology industry continues its evolution, leadership opportunities and venture capital are two major factors driving the trend. However, female biotech entrepreneurs often face a…

United States biotechnology companies are currently engaged in an industry-wide regeneration. In February 2023, RBC Capital Markets presented an intensive biotech industry market analysis that addressed the factors behind the sector’s recent slowdowns. …

Dr. Leen Kawas highlights the uses of blockchain technology within the medical industry. In the ever-evolving digital data arena, Blockchain technology has changed the nature of the playing field. Blockchain’s increased transparency, better security, and real-time traceability are driving the technology’s dynamic growth. Blockchain technology can deliver business benefits The 21st-century business landscape relies on stakeholders’…